Back to the search results

Klinikum Chemnitz gGmbH

Klinikum Chemnitz gGmbH
Klinikum Chemnitz gGmbH

Flemmingstraße 2
09116 Chemnitz

Phone: 0371-33332460
Fax: 0371-333-33202
Mail: ed.cks@tkatnok

http://www.klinikumchemnitz.de
  • Number of beds: 1.384
  • Number of specialist departments: 21
  • Number of inpatient cases: 49.209
  • Number of partial inpatient cases: 6.323
  • Number of outpatient cases: 92.710
  • Hospital owners: Stadt Chemnitz
  • Type of provider: öffentlich
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Koronare Herzkrankheit (KHK)

seit 2004

Quantity performed 34
Exception? No exception
Quantity performed 92
Exception? No exception
Quantity performed 29
Exception? No exception
Quantity performed 83
Exception? No exception
Quantity performed 52
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 34
Quantity forecast year: 24
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 92
Quantity forecast year: 98
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 29
Quantity forecast year: 32
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 83
Quantity forecast year: 97
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 52
Quantity forecast year: 28
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 128
Quantity forecast year: 132
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 106
Quantity forecast year: 92
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ02 Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ24 Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ27 Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR)
CQ28 Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)
CQ29
CQ30 Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021).
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
381 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
272 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
201 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • Measures
    • Prevention
    • Intervention
      • Note on the measure

        Kinderschutzgruppe am Klinikum Chemnitz etabliert

    • Review
  • Kinderschutzgruppe am Klinikum Chemnitz etabliert
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

VA Umgang mit Arzneimitteln (KC-PATV-VA-00001) Formular Arzneimittelanamnese (KC-APO-FB-00001)

11.05.2023

VA Umgang mit Arzneimitteln (KC-PATV-VA-00001)

11.05.2023

VA Umgang mit Arzneimitteln (KC-PATV-VA-00001), AA Entlassmanagement (KC-PV-AA-00009)

11.05.2023

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Medikationsmanagement in 4 Kliniken; AM-Anamnese durch Apotheker in 2 Kliniken; Stationsapotheker; Bearbeitung von Aufnahmemedikation als Anfrage von Station, patientenindividuelle parenterale Ernähru
  • Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)
  • Bestellung über WebMUSE; gesamte individuelle Herstellung, Abgabe erfolgt über ein Warenwirtschaftssystem und Herstellungsprogramme; Einführung Arztmodul zur elektr. Anforderung von onkologischen Zube
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Meldung von beinahe- und stattgefunden Medikationsfehlern, detaillierte Analyse der Medikationsfehler, um ggf. Schwerpunkte festzustellen und Maßnahmen daraus abzuleiten; bei Arzneimittelumstellung Nu
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
  • Projekt: Entlassgespräch zur Arzneimitteltherapie durch pharmazeutisches Personal in der Geriatrie
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Modellstudiengang MEDiC seit 2019 mit 50 Studierenden pro Jahr

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Generalistische Pflege

Comment

Generalistische Pflege

Comment

Duales Studium Hebammenkunde - Praxispartner der Uni Leipzig und Uni Dresden

Comment

Comment

Comment

Comment

Comment

Comment

Comment

Generalistische Pflege

Herr Peter Scheffler

Patientenfürsprecher

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-42746
Mail: ed.cks@wk.rehcerpsreufnetneitap

Frau Marion Franke

Patientenfürsprecherin

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-33648
Mail: ed.cks@lf.rehcerpsreufnetneitap

Leslie Nürnberger

Lob- und Beschwerdemanagerin

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-32490
Mail: ed.cks@regrebnreun.l

Janna Worms

Leitung Medizinisches Qualitäts- und Risikomanagement

Flemmingstraße 2
09116 Chemnitz

Phone: 49 -371-33332476
Mail: ed.cks@smrow.annaj

Prof. Dr. med. habil. Ralf Steinmeier

Medizinischer Geschäftsführer

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-33200
Mail: ed.cks@reiemniets

Prof. Dr. med. habil. Stefan Hammerschmidt

Vorsitzender der Arzneimittelkommission

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-43551
Mail: ed.cks@tdimhcsremmah.s

Markus Kunert

Inklusionsbeauftragter

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-34120
Mail: ed.cks@trenuk.m

Flemmingstraße 2
09116 Chemnitz

Phone: 0371-33332460
Fax: 0371-333-33202
Mail: ed.cks@tkatnok

Dipl.- Pflegewirtin (FH) Ines Haselhoff

Pflegedirektorin

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-33241
Mail: ed.cks@ffohlesah.i

Martin Jonas

Kaufmännischer Geschäftsführer

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-32460
Mail: ed.cks@sanoj.nitram

Prof. Dr. med. Martin Wolz

Medizinischer Geschäftsführer

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-33200
Mail: ed.cks@zlow.nitram

Prof. Dr. med. habil. Ralf Steinmeier

Medizinischer Geschäftsführer

Flemmingstraße 2
09116 Chemnitz

Phone: 0371 -333-33200
Mail: ed.cks@reiemniets

No

IK: 261401416

Location number: 772794000

Hospital portrait for download